Glaukos Launches Epioxa: First FDA-Approved Incision-Free Topical Therapy for Keratoconus is Now Commercially Available
Market Chameleon (Fri, 20-Mar 10:28 AM)
Stifel Nicolaus Sticks to Its Buy Rating for Glaukos (GKOS)
at www.tipranks.com (Fri, 20-Mar 9:17 AM)
Glaukos Launches Epioxa: First FDA-Approved Topical Drug for Keratoconus Ushers in Transformative Eye Care
Market Chameleon (Thu, 19-Mar 9:06 AM)
